Surgical Science Sweden AB (publ)
SUSRF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $144,320 | $189,153 | $162,537 | $56,523 |
| Dep. & Amort. | $0 | $55,613 | $51,585 | $33,517 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$65,888 | -$5,653 | -$65,609 | -$46,687 |
| Other Non-Cash | $58,793 | -$822 | -$19,026 | -$4,270 |
| Operating Cash Flow | $137,225 | $238,291 | $129,487 | $39,083 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$6,104 | -$10,456 | -$34,548 | -$14,377 |
| Net Acquisitions | $0 | $0 | $0 | -$2,718,237 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$41,426 | -$33,673 | -$25,196 | -$10,506 |
| Investing Cash Flow | -$47,530 | -$44,129 | -$34,548 | -$2,732,614 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$7,755 | $0 | $0 | -$24,169 |
| Stock Issued | $0 | $19,148 | $0 | $3,039,053 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $235,408 | -$3,301 | $17,093 | -$92,421 |
| Financing Cash Flow | $227,653 | $15,847 | $17,093 | $2,922,463 |
| Forex Effect | $16,441 | -$9,375 | $5,021 | $591 |
| Net Chg. in Cash | $333,789 | $200,633 | $117,053 | $229,523 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $634,366 | $433,733 | $316,680 | $87,157 |
| End Cash | $968,155 | $634,366 | $433,733 | $316,680 |
| Free Cash Flow | $89,695 | $194,162 | $94,939 | $24,706 |